journal article·2022-09-22Open access

Degradable poly(catechin) nanoparticles as a versatile therapeutic agent

Selin S. Suner, Mehtap Sahiner, Subhra Mohapatra, Ramesh S. Ayyala, Venkat R. Bhethanabotla, Nurettin Sahiner

Abstract

Poly(catechin) (p(CAT)) nanoparticles (NPs), 173 ± 4 nm was prepared as a therapeutic agent with hydrolytic degradability affording sustainable CAT release over 20 d at carcinogenic conditions, pH 5.5 and 37.5 °C. Cell viability studies on MC38 colon cancer cells revealed the anticancer potential of p(CAT) NPs with 691 µg/mL IC50 value while being well-tolerated by nonmalignant CCD841 CoN colon cells at 72 h incubation-time. P(CAT) NPs showed effective antioxidant capacity with 241 ± 7 and 456 ± 54 µg/mL of GA equivalency of total phenol content (TPC), and total flavonoid content (TFC) values and 1.19 ± 0.8 µmol/g Trolox equivalent antioxidant capacity by 2,2'-Azino-bis-(3-ethylbenzothioazoline-6-sulfonic acid (ABTS•+) scavenging assay.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Tea Polyphenols and Effects · Nanoparticle-Based Drug Delivery · Phytochemicals and Antioxidant Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Faculty of Sciences & Arts, and Nanoscience and Technology Research and Application Center (NANORAC), Canakkale Onsekiz Mart University

Department of Fashion Design, Canakkale Applied Science, Canakkale Onsekiz Mart University

Department of Molecular Medicine, Morsani College of Medicine, University of South Florida

Department of Ophthalmology, Morsani College of Medicine, University of South Florida Eye Institute

Department of Chemical, Biological, and Materials Science and Engineering Program, University of South Florida

Funding

The Scientific and Technological Research Council of Turkey · University of South Florida start-up fund to NS

References (57)

Show source-provided references
1. 10.1093/jn/133.10.3255S10.1093/jn/133.10.3255S ↗
2. 10.3390/molecules2112167910.3390/molecules21121679 ↗
3. 10.1080/1040869039082646410.1080/10408690390826464 ↗
4. 10.1016/j.lfs.2005.12.00610.1016/j.lfs.2005.12.006 ↗
5. 10.1016/j.rbmo.2017.02.00610.1016/j.rbmo.2017.02.006 ↗
6. 10.1016/j.foodres.2020.10927110.1016/j.foodres.2020.109271 ↗
7. 10.1113/expphysiol.1997.sp00402410.1113/expphysiol.1997.sp004024 ↗
8. 10.1016/j.ejphar.2006.06.02510.1016/j.ejphar.2006.06.025 ↗
9. 10.1039/c9fo00990f10.1039/c9fo00990f ↗
10. 10.1093/carcin/21.1.6310.1093/carcin/21.1.63 ↗
11. 10.1016/j.imr.2013.12.00110.1016/j.imr.2013.12.001 ↗
12. 10.1038/nrc264110.1038/nrc2641 ↗
13. 10.1016/j.phrs.2011.03.00210.1016/j.phrs.2011.03.002 ↗
14. 10.1016/j.jvoice.2016.11.01410.1016/j.jvoice.2016.11.014 ↗
15. 10.1054/bjoc.2000.169110.1054/bjoc.2000.1691 ↗
16. 10.1007/s11095-012-0790-910.1007/s11095-012-0790-9 ↗
17. 10.1016/j.fct.2011.09.02310.1016/j.fct.2011.09.023 ↗
18. 10.1186/1756-9966-29-16710.1186/1756-9966-29-167 ↗
19. Leone, M.; Zhai, D.; Sareth, S.; Kitada, S.; Reed, J. C.; Pellecchia, M. Cancer Prevention by Tea Polyphenols is Linked to Their Direct Inhibition of Antiapoptotic Bcl-2-Family Proteins. Cancer Res. 2003, 63, 8118–8121.
20. 10.3390/ijms1902044810.3390/ijms19020448 ↗
21. 10.1016/j.ijpharm.2019.05.03410.1016/j.ijpharm.2019.05.034 ↗
22. 10.1038/s41392-017-0004-310.1038/s41392-017-0004-3 ↗
23. 10.1016/s0378-5173(01)00923-110.1016/s0378-5173(01)00923-1 ↗
24. 10.1039/c6cs00636a10.1039/c6cs00636a ↗
25. 10.1080/1061186070179435310.1080/10611860701794353 ↗
26. 10.1016/j.ijpharm.2020.11931410.1016/j.ijpharm.2020.119314 ↗
27. 10.1016/j.colsurfa.2014.03.09710.1016/j.colsurfa.2014.03.097 ↗
28. 10.1016/j.colsurfb.2016.03.00610.1016/j.colsurfb.2016.03.006 ↗
29. 10.1182/blood-2007-12-07738810.1182/blood-2007-12-077388 ↗
30. 10.1039/c2dt12159j10.1039/c2dt12159j ↗
31. 10.4155/fmc.09.12110.4155/fmc.09.121 ↗
32. 10.2174/092986703345763810.2174/0929867033457638 ↗
33. 10.1016/j.saa.2020.11851910.1016/j.saa.2020.118519 ↗
34. 10.1016/j.ejmech.2018.07.02610.1016/j.ejmech.2018.07.026 ↗
35. 10.1002/mnfr.20120020610.1002/mnfr.201200206 ↗
36. 10.1016/j.cj.2015.04.00410.1016/j.cj.2015.04.004 ↗
37. 10.1021/jf203505910.1021/jf2035059 ↗
38. 10.1155/2014/17986510.1155/2014/179865 ↗
39. 10.1002/jcp.2912610.1002/jcp.29126 ↗
40. 10.1016/j.foodhyd.2012.04.01410.1016/j.foodhyd.2012.04.014 ↗
41. 10.3390/molecules2306129710.3390/molecules23061297 ↗
42. 10.1021/jf062767210.1021/jf0627672 ↗
43. 10.1016/j.jff.2020.10417210.1016/j.jff.2020.104172 ↗
44. 10.1093/carcin/20.1.18110.1093/carcin/20.1.181 ↗
45. 10.2741/36310.2741/363 ↗
46. 10.1017/S000711450999174710.1017/S0007114509991747 ↗
47. 10.1080/00914037.2020.180940710.1080/00914037.2020.1809407 ↗
48. 10.1080/00914037.2020.176761810.1080/00914037.2020.1767618 ↗
49. 10.1016/j.lfs.2021.11943610.1016/j.lfs.2021.119436 ↗
50. 10.1002/anie.20140303610.1002/anie.201403036 ↗
51. 10.1016/s0169-409x(02)00044-310.1016/s0169-409x(02)00044-3 ↗
52. 10.1080/00914037.2016.123341810.1080/00914037.2016.1233418 ↗
53. 10.1111/j.1541-4337.2011.00156.x10.1111/j.1541-4337.2011.00156.x ↗
54. 10.1039/c3ay41125g10.1039/c3ay41125g ↗
55. 10.1016/S0076-6879(01)35243-610.1016/S0076-6879(01)35243-6 ↗
56. 10.1016/j.bbadis.2005.06.00610.1016/j.bbadis.2005.06.006 ↗
57. 10.1021/jf505425d10.1021/jf505425d ↗